MD Anderson Study Shows Differential RNA Editing in Cancer Cells | GenomeWeb

NEW YORK (GenomeWeb) – Cancer cells show different patterns of post-transcriptional RNA editing compared to normal cells, a new study shows, and the changes could be developed into biomarkers and potentially offer druggable targets.

Led by Leng Han, Lixia Diao, Gordon Mills, and Han Liang of MD Anderson Cancer Center, the scientists published a study today in Cancer Cell detailing the clinical relevance of adenosine to inosine (A-to-I) RNA editing in human cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

In Nature this week: genetic history of HIV in the US, and more.

Sponsored by
Agilent Technologies

This webinar will provide specific use cases from a molecular pathology lab demonstrating how an automated bioinformatics pipeline can improve somatic variant assessment and reporting.

Sponsored by
Personal Genome Diagnostics

This online seminar will discuss the application of circulating tumor DNA (ctDNA) sequencing to evaluate the emergence of resistance mutations during therapy.